BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38687946)

  • 1. Effect of stability of PTEN on hepatocellular carcinoma.
    Hu Y; Mei H; Luan T; Sun H; Lu Q; Liu R
    J Cancer Res Ther; 2024 Apr; 20(2):726-735. PubMed ID: 38687946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circ_0004018 suppresses cell proliferation and migration in hepatocellular carcinoma via miR-1197/PTEN/PI3K/AKT signaling pathway.
    Wang H; Zhang Q; Cui W; Li W; Zhang J
    Cell Cycle; 2021 Oct; 20(20):2125-2136. PubMed ID: 34570663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA 657 suppresses hepatocellular carcinoma cell growth by acting as a molecular sponge of miR-106a-5p to regulate PTEN expression.
    Hu B; Cai H; Zheng R; Yang S; Zhou Z; Tu J
    Int J Biochem Cell Biol; 2017 Nov; 92():34-42. PubMed ID: 28919047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-367 promotes proliferation and invasion of hepatocellular carcinoma cells by negatively regulating PTEN.
    Meng X; Lu P; Fan Q
    Biochem Biophys Res Commun; 2016 Jan; 470(1):187-191. PubMed ID: 26772880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-218 modulate hepatocellular carcinoma cell proliferation through PTEN/AKT/PI3K pathway and HoxA10.
    Xiao ZD; Jiao CY; Huang HT; He LJ; Zhao JJ; Lu ZY; Liu LX
    Int J Clin Exp Pathol; 2014; 7(7):4039-44. PubMed ID: 25120782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XIST Induced by JPX Suppresses Hepatocellular Carcinoma by Sponging miR-155-5p.
    Lin XQ; Huang ZM; Chen X; Wu F; Wu W
    Yonsei Med J; 2018 Sep; 59(7):816-826. PubMed ID: 30091314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Roles of miR-590-5p and miR-590-3p in the development of hepatocellular carcinoma].
    Yang H; Zheng W; Zhao W; Guan C; An J
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):804-11. PubMed ID: 23803188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA TCL6 binds to miR-106a-5p to regulate hepatocellular carcinoma cells through PI3K/AKT signaling pathway.
    Luo LH; Jin M; Wang LQ; Xu GJ; Lin ZY; Yu DD; Yang SL; Ran RZ; Wu G; Zhang T
    J Cell Physiol; 2020 Sep; 235(9):6154-6166. PubMed ID: 32020591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA circHIAT1 inhibits cell growth in hepatocellular carcinoma by regulating miR-3171/PTEN axis.
    Wang Z; Zhao Y; Wang Y; Jin C
    Biomed Pharmacother; 2019 Aug; 116():108932. PubMed ID: 31108351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pterostilbene increases PTEN expression through the targeted downregulation of microRNA-19a in hepatocellular carcinoma.
    Qian YY; Liu ZS; Zhang Z; Levenson AS; Li K
    Mol Med Rep; 2018 Apr; 17(4):5193-5201. PubMed ID: 29393488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN.
    Liu K; Liu S; Zhang W; Jia B; Tan L; Jin Z; Liu Y
    Oncol Rep; 2015 Aug; 34(2):1003-10. PubMed ID: 26045065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway.
    Fu X; Liu M; Qu S; Ma J; Zhang Y; Shi T; Wen H; Yang Y; Wang S; Wang J; Nan K; Yao Y; Tian T
    J Exp Clin Cancer Res; 2018 Mar; 37(1):52. PubMed ID: 29530052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effects of miR-101 on prognosis of hepatocellular carcinoma and carcinogenic mechanism of anti-miR-101.
    Lv X; Li J; Yang B
    Oncol Rep; 2016 Oct; 36(4):2184-92. PubMed ID: 27498785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA ITCH increases sorafenib-sensitivity in hepatocellular carcinoma via sequestering miR-20b-5p and modulating the downstream PTEN-PI3K/Akt pathway.
    Li X; Yin X; Bao H; Liu C
    Mol Cell Probes; 2023 Feb; 67():101877. PubMed ID: 36442661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma.
    Yang B; Feng X; Liu H; Tong R; Wu J; Li C; Yu H; Chen Y; Cheng Q; Chen J; Cai X; Wu W; Lu Y; Hu J; Liang K; Lv Z; Wu J; Zheng S
    Oncogene; 2020 Oct; 39(42):6529-6543. PubMed ID: 32917956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosome-Mediated MiR-155 Transfer Contributes to Hepatocellular Carcinoma Cell Proliferation by Targeting PTEN.
    Sun JF; Zhang D; Gao CJ; Zhang YW; Dai QS
    Med Sci Monit Basic Res; 2019 Oct; 25():218-228. PubMed ID: 31645540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway.
    Song W; Zhang J; Xia Q; Sun M
    Cell Cycle; 2019 Nov; 18(22):3177-3188. PubMed ID: 31564201
    [No Abstract]   [Full Text] [Related]  

  • 19. Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression.
    Chang S; Chen B; Wang X; Wu K; Sun Y
    BMC Cancer; 2017 Apr; 17(1):248. PubMed ID: 28388883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal miR-93 derived from hepatocellular carcinoma cell promotes the sorafenib resistance of hepatocellular carcinoma through PTEN/PI3K/Akt pathway.
    Bao Y; Xu S; Zhou J; Zhao C; Dai S; Zhang Y; Rao M
    J Biochem Mol Toxicol; 2024 Mar; 38(3):e23666. PubMed ID: 38375688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.